Common Contracts

SECOND AMENDMENT TO THE LICENSE AGREEMENT

The License Agreement • March 11th, 2024 • Lirum Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  The License Agreement
• Filed
  March 11th, 2024
• Company
  Lirum Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

This Second Amendment to the License Agreement (this “Second Amendment”) is made and entered into this 11th day of July 2023, by and among IGF Oncology, LLC, a Delaware limited liability company (“IGF”), and Lirum Therapeutics, Inc., a Delaware corporation (“LIRUM”). IGF and LIRUM are from time to time referred to herein individually as a “Party” or collectively as the “Parties”.

SECOND AMENDMENT TO THE LICENSE AGREEMENT

The License Agreement • February 2nd, 2024 • Lirum Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  The License Agreement
• Filed
  February 2nd, 2024
• Company
  Lirum Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

This Second Amendment to the License Agreement (this “Second Amendment”) is made and entered into this [11th] day of July 2023, by and among IGF Oncology, LLC, a Delaware limited liability company (“IGF”), and Lirum Therapeutics, Inc., a Delaware corporation (“LIRUM”). IGF and LIRUM are from time to time referred to herein individually as a “Party” or collectively as the “Parties”.